Back to News
Dec 10, 2025 4:00 PM

CVS Health Is Seeing Margin And App Momentum, Analyst Highlights

On Tuesday, CVS Health Inc. (NYSE:CVS) projected 2025 revenue of at least $400 billion versus the consensus of $394.59 billion, with operating income of $4.37 billion to $4.54 billion.

The drug retailer raised its sales guidance to at least $397.3 billion.

Analyst Take

Bank of America said it attended CVS's investor day. Analyst Allen Lutz on Wednesday wrote, "We come away incrementally positive on the enterprise growth trajectory. We also believe CVS's emerging consumer app makes CVS's pharmacy assets a differentiator that can drive structurally higher retention for Aetna and Caremark over time."

Also Read: CMS Unveils 2027 Rule To Refocus Medicare Advantage On Outcomes

Analyst Lutz said CVS remains firm on its plan to restore target margins at Aetna, even as its Medicare Advantage margin outlook has been reset to 3%–4% for 2025, down from 4%–5% in ...